drug development News
Most Popular drug development Story
Patheon reveals strategy amid poor financials
James Mullen, the former CEO of Biogen Idec ($BIIB), is facing some new challenges at the helm of contract manufacturing outfit Patheon ($TSX:PTI). Mullen, who stepped up as CEO and president in Read more...
Latest Headlines
- November 16, 2011
- September 19, 2011
- September 12, 2011
- August 26, 2011
- February 17, 2010
- July 7, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
